| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.30▼ | 4.29▲ | 4.29▲ | 4.34▼ | 3.81▲ |
| MA10 | 4.29▲ | 4.29▲ | 4.35▼ | 4.00▲ | 4.39▼ |
| MA20 | 4.29▲ | 4.33▼ | 4.34▼ | 3.81▲ | 5.03▼ |
| MA50 | 4.29▲ | 4.29▲ | 4.07▲ | 4.50▼ | 5.07▼ |
| MA100 | 4.34▼ | 4.03▲ | 3.81▲ | 5.20▼ | 3.92▲ |
| MA200 | 4.33▼ | 3.79▲ | 3.89▲ | 5.16▼ | 3.96▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.012▼ | -0.032▼ | 0.152▲ | -0.181▼ |
| RSI | 51.845▲ | 49.594▼ | 52.825▲ | 54.255▲ | 44.720▼ |
| STOCH | 51.667 | 27.352 | 19.444▼ | 82.907▲ | 12.930▼ |
| WILL %R | -60.000 | -82.759▼ | -69.565 | -31.655 | -64.945 |
| CCI | 59.927 | -14.141 | -34.262 | 107.097▲ | -40.913 |
| MA | $IVA Price Crossed Below MA(50) | Set Alert |
|
Thursday, July 09, 2026 01:29 PM
July 9, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of an oral therapy for the treatment of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/07/26 | 4.50 | 4.51 | 4.245 | 4.30 | 562,538 |
| 09/07/26 | 4.33 | 4.545 | 4.195 | 4.53 | 1,780,747 |
| 08/07/26 | 4.27 | 4.74 | 4.195 | 4.39 | 3,403,278 |
| 07/07/26 | 3.87 | 4.61 | 3.76 | 4.56 | 3,291,436 |
| 06/07/26 | 3.895 | 4.00 | 3.82 | 3.90 | 3,001,024 |
| 02/07/26 | 3.70 | 3.965 | 3.67 | 3.91 | 1,830,105 |
| 01/07/26 | 3.75 | 3.79 | 3.53 | 3.69 | 1,713,936 |
| 30/06/26 | 3.59 | 3.80 | 3.54 | 3.78 | 2,093,777 |
| 29/06/26 | 3.53 | 3.56 | 3.445 | 3.55 | 1,176,051 |
| 26/06/26 | 3.44 | 3.58 | 3.35 | 3.41 | 1,335,146 |
|
|
||||
|
|
||||
|
|